Mulmit

Minerva Neurosciences, Inc.Minerva Neurosciences, Inc.

NERV Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2024-12-310-21,848,3861,438,8650.19
2023-12-310-23,119,576-30,005,353-4.61
2022-12-310-25,231,326-32,108,676-6.01
2021-12-310-45,365,657-49,905,952-9.35
2020-12-3101,846,7471,940,7710.05

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-03Kaul Inderjit12,147
2026-06-03Kaul Inderjit50,000
2026-06-03Kupfer David50,000
2026-06-03Laghrissi-Thode Fouzia50,000
2026-06-03Luthringer RemyCEO1,690,700
2026-06-03Ahlholm Frederick WSVP, CFO and Secretary680,000
2026-06-03HASLER HANS PETER50,000
2026-06-03VAN HEEK G JAN50,000
2026-04-21O'Connor James JosephChief Business Officer and GC350,800
2026-03-31Kaul Inderjit12,169
2025-12-22Kaul Inderjit364,504
2025-12-22Kupfer David50,000

8-K events

FiledItems
2026-08-12Officer or director change
2026-08-07Results of operations · Financial statements and exhibits
2026-06-04Material modification to rights of security holders · Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-05-27Entry into a material agreement · Other events · Financial statements and exhibits
2026-05-05Results of operations · Financial statements and exhibits
2026-04-06Other events
2026-04-02Officer or director change · Regulation FD disclosure · Other events · Financial statements and exhibits
2026-03-11Results of operations · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.